TAILIEUCHUNG - Doctoral thesis summary: Research antiphospholipid syndrome in pregnant women with a history of RPL by 12 weeks

Research objectives: To analyse of obstetric history and characteristics of anticardiolipin antibody and lupus anticoagulant in pregnant women with a history of RPL; assess the effectiveness of treatment pregnancy in women with a history of RPL by antiphospholipid syndrome by coordinating regimen low doses of aspirin and low molecular weight heparin. | 1 INTRODUCTION 1. Urgency of topics Recurrent pregnancy loss RPL are a common maternity pathology affects 1-3 pregnancy. RPL is defined as having 3 times more consecutive miscarriages eliminating cases of ectopic pregnancy hydartiform mole and fetal biochemical abortion should under 20 weeks. The most common causes and can be cured completely of RPL is antiphospholipid syndrome APS the antiphospholipid antibody aPL causes thrombose in the placenta vessels which triggers RPL in the first 3 months stillbirth fetal growth retardation or premature severe preeclampsia and so on. Diagnosis and treatment APS can raise the live birth rate from 20 up to 80 . Since 2009 Vietnam obstetricians has begun to learn and initially identified the role of APS in RPL. However obstetric physicians realize that there are many obstacles in the application of criteria for diagnosing subclinical syndrome in patient populations of RPL. Several studies conducted in Vietnam has not yet fully examined the two main types of aPL or not tested twice for patients with positive result to eliminate fault positive cases. Therefore the theme Research antiphospholipid syndrome in pregnant women with a history of RPL by 12 weeks was conducted with two objectives 1 To analyse of obstetric history and characteristics of anticardiolipin antibody and lupus anticoagulant in pregnant women with a history ofRPL. 2 To assess the effectiveness of treatment pregnancy in women with a history of RPL by antiphospholipid syndrome by coordinating regimen low doses of aspirin and low molecular weight heparin. 2 2. New contributions of topics 1 Research conducted on a large enough sample 301 pregnant women with a history of RPL and patients have been tested 2 main antibodies aCL and LA. The study tested 2 times for the positive cases in order to eliminate all cases of transient positive. The study results showed that is the most common cause of RPL accounted for 11 29 . 2 The study has identified the primary aPL in RPL

• Thạc sĩ - Tiến sĩ - Cao học
• Antiphospholipid syndrome
• Pregnant women
• Patient populations
• Antiphospholipid antibody
• Doctoral thesis summary
• Mechanisms Involved
• Antiphospholipid Antibodies Action
• Antibodies Detection
• Clinical Manifestation
• Genetics of Antiphospholipid
• Antiphospholipid Antibodies
• Detection and Clinical Importance
• Antibodies Against
• Multisystemic Disease
• Pregnancy
• Pathophysiologic Mechanisms
• Affected Pregnancy
• Failures – Controversies
• Syndrome in Pregnancy
• BMC Pediatrics
• Central retinal vein occlusion
• Systemic lupus erythematosus
• Antiphospholipid antibody syndrome
• Anti phosphatidylcholine antibody
• Antiphospholipid
• Syndrome
• Alena Bulikova
• Health
• Sciences
• medicine
• pharmacolocy
• báo cáo khoa học
• báo cáo y học
• công trình nghiên cứu về y học
• tài liệu về y học
• cách trình bày báo cáo
• trình bày báo cáo
• tài liệu báo cáo khoa học
• kiến thức y học
• nghiên cứu y học
• tạp chí y học Medical Sciences
• new drug regimens
• Expanded discussion
• Drug information
• bibliographies
• complementary therapies
• lipid disorders
• Recurrent miscarriage
• Including cervical incompetence
• Endocrine factors
• Inherited thrombophilia
• Harrisons principles of internal medicine
• Acute rheumatic fever
• Inflammatory myopathies
• Relapsing polychondritis
• Pituitary tumor syndromes
• BMC Biotechnology
• Protein production
• Inclusion bodies
• E Coli
• Beta 2 Glycoprotein I
• Harrisons rheumatology
• The immune system in health
• Introduction to the immune system